Jochen Kammermeier

2.3k total citations · 1 hit paper
16 papers, 672 citations indexed

About

Jochen Kammermeier is a scholar working on Genetics, Surgery and Immunology. According to data from OpenAlex, Jochen Kammermeier has authored 16 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 5 papers in Surgery and 5 papers in Immunology. Recurrent topics in Jochen Kammermeier's work include Inflammatory Bowel Disease (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Digestive system and related health (2 papers). Jochen Kammermeier is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Digestive system and related health (2 papers). Jochen Kammermeier collaborates with scholars based in United Kingdom, Netherlands and Israel. Jochen Kammermeier's co-authors include Neil Shah, Holm H. Uhlig, Simon Travis, David C. Wilson, Abdul Elkadri, Tobias Schwerd, Scott B. Snapper, Christoph Klein, Jodie Ouahed and Dan Turner and has published in prestigious journals such as Gastroenterology, PEDIATRICS and Archives of Disease in Childhood.

In The Last Decade

Jochen Kammermeier

15 papers receiving 665 citations

Hit Papers

The Diagnostic Approach to Monogenic Very Early Onset Inf... 2014 2026 2018 2022 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jochen Kammermeier United Kingdom 8 426 318 237 150 93 16 672
Jodie Ouahed United States 9 426 1.0× 434 1.4× 219 0.9× 161 1.1× 171 1.8× 18 844
Christine Martinez‐Vinson France 15 303 0.7× 211 0.7× 190 0.8× 177 1.2× 115 1.2× 42 635
Filip J. Baert Belgium 12 461 1.1× 204 0.6× 184 0.8× 340 2.3× 83 0.9× 35 704
Alon D. Levin Netherlands 8 237 0.6× 175 0.6× 100 0.4× 190 1.3× 98 1.1× 9 538
Hiromitsu Ban Japan 10 221 0.5× 323 1.0× 176 0.7× 143 1.0× 61 0.7× 16 570
Julien Verdier France 12 197 0.5× 184 0.6× 121 0.5× 123 0.8× 140 1.5× 22 509
S Vavricka Switzerland 12 236 0.6× 149 0.5× 275 1.2× 153 1.0× 119 1.3× 27 649
Eric Vasiliauskas United States 13 616 1.4× 221 0.7× 238 1.0× 470 3.1× 123 1.3× 20 894
Benedetta Mattioli Italy 10 140 0.3× 438 1.4× 379 1.6× 81 0.5× 159 1.7× 27 765
Marta Vernero Italy 14 229 0.5× 96 0.3× 118 0.5× 199 1.3× 76 0.8× 37 485

Countries citing papers authored by Jochen Kammermeier

Since Specialization
Citations

This map shows the geographic impact of Jochen Kammermeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Kammermeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Kammermeier more than expected).

Fields of papers citing papers by Jochen Kammermeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Kammermeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Kammermeier. The network helps show where Jochen Kammermeier may publish in the future.

Co-authorship network of co-authors of Jochen Kammermeier

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Kammermeier. A scholar is included among the top collaborators of Jochen Kammermeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Kammermeier. Jochen Kammermeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gasparetto, Marco, Priya Narula, James J. Ashton, et al.. (2024). P801 Umbrella review of effectiveness of digital technologies for the management of Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 18(Supplement_1). i1484–i1485.
2.
Ashton, James J., et al.. (2024). Therapeutic options for children and young people with moderate-to-severe ulcerative colitis. Frontline Gastroenterology. 15(5). 387–394. 1 indexed citations
3.
Narula, Priya, Marco Gasparetto, Shaji Sebastian, et al.. (2024). Top 10 research priorities for digital technology for adolescents and young persons with inflammatory bowel disease: Results of a James Lind Alliance Priority Setting Partnership. Journal of Pediatric Gastroenterology and Nutrition. 78(3). 670–676. 2 indexed citations
4.
Ashton, James J., Kelsey Jones, Astor Rodrigues, et al.. (2023). Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study. Archives of Disease in Childhood. 108(12). 994–998. 1 indexed citations
5.
Torrente, Franco, Susanna Meade, Eric I. Benchimol, et al.. (2022). Thromboprophylaxis Use in Paediatric Inflammatory Bowel Disease: An International RAND Appropriateness Panel. Journal of Crohn s and Colitis. 16(10). 1609–1616. 7 indexed citations
6.
Jones, Kelsey, et al.. (2022). Monogenic inflammatory bowel disease-genetic variants, functional mechanisms and personalised medicine in clinical practice. Human Genetics. 142(5). 599–611. 8 indexed citations
7.
Hansen, Richard, Susanna Meade, Franco Torrente, et al.. (2022). P590 Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel. Journal of Crohn s and Colitis. 16(Supplement_1). i526–i527. 1 indexed citations
8.
Mutalib, Mohamed, Jochen Kammermeier, Rakesh Vora, & Osvaldo Borrelli. (2021). Prucalopride in intestinal pseudo obstruction, paediatric experience and systematic review. Acta Gastro Enterologica Belgica. 84(3). 429–434. 7 indexed citations
9.
Din, Shahida, Daniel R. Gaya, Jochen Kammermeier, et al.. (2021). Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic. Frontline Gastroenterology. 13(1). 77–81. 3 indexed citations
10.
Kammermeier, Jochen, et al.. (2018). The Use of Pyridostigmine in a Child With Chronic Intestinal Pseudo-Obstruction. PEDIATRICS. 141(Supplement_5). S404–S407. 12 indexed citations
11.
Mutalib, Mohamed, et al.. (2017). Management of pneumatosis intestinalis in children over the age of 6 months: a conservative approach. Archives of Disease in Childhood. 103(4). 352–355. 13 indexed citations
12.
Kammermeier, Jochen, Mary‐Anne Morris, Vikki Garrick, et al.. (2015). Management of Crohn's disease. Archives of Disease in Childhood. 101(5). 475–480. 33 indexed citations
13.
Uhlig, Holm H., Tobias Schwerd, Sibylle Koletzko, et al.. (2014). The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease. Gastroenterology. 147(5). 990–1007.e3. 437 indexed citations breakdown →
14.
Worth, Austen, Zohreh Nademi, Jochen Kammermeier, et al.. (2014). Allogeneic Stem Cell Transplant Offers Cure for Intractable Childhood Enteropathy. Biology of Blood and Marrow Transplantation. 20(2). S89–S90. 2 indexed citations
15.
Kammermeier, Jochen, Suzanne Drury, Chela James, et al.. (2014). Targeted gene panel sequencing in children with very early onset inflammatory bowel disease—evaluation and prospective analysis. Journal of Medical Genetics. 51(11). 748–755. 67 indexed citations
16.
Shah, Neil, Jochen Kammermeier, Mamoun Elawad, & Erik‐Oliver Glocker. (2012). Interleukin-10 and Interleukin-10–Receptor Defects in Inflammatory Bowel Disease. Current Allergy and Asthma Reports. 12(5). 373–379. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026